G2M | Next Generation IVD solutions for Genomics
Neeraj Gupta has an extensive work experience, starting in 1992 when they joined Imperial Life Sciences as the Director of Sales & Marketing. In 2016, they founded and became the CEO of Genes2me.
Neeraj Gupta attended IMS for an MBA degree. Neeraj also attended St. Stephen's school, but no specific degree or field of study information is provided.
This person is not in any teams
This person is not in any offices
G2M | Next Generation IVD solutions for Genomics
Genes2Me is India's leading IVD solutions manufacturer which offers NGS clinical panels, molecular POC testing solutions, RT-PCR kits, rapid antigen/antibody testing kits, and molecular biology reagents. Additionally, Company is also a renowned genetic testing service provider with a wide range of tests targeting infectious and non-infectious diseases, oncology, rare diseases, and prenatal/postnatal genetic diseases. NGS clinical assays from Genes2Me allow targeted testing for Oncology, Liquid Biopsy, cardiovascular conditions, neurological disorders, HLA typing, etc. With engaging innovative approaches and new ideas, the company’s flagship products Rapi-Q/ Rapi-Q HT and Rapid POC RT-PCR device are revolutionary innovations that shall change the paradigm of molecular Point of Care testing across the world. Brands: CliSeq NGS clinical panels, PanCan, Med4Me, Exome CliSeq, CliSeq LiqBio, Rapi-Q / Rapi-Q HT, Rapi-X 16, Rapi-X 96, RapiCycler 96, RT-Direct, CoviEasy, LeoNext